Clinical Trial

Enhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients

Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this interventional study is to learn if an Enhanced Recovery After Surgery (ERAS) protocol works to reduce the need for narcotic pain medications in live donor kidney transplant recipients. The main questions it aims to answer are: Does the ERAS protocol lower the amount of opioid narcotic medication needed to manage post-surgery pain? Does the ERAS protocol help lower pain scores after surgery? Researchers will compare the ERAS protocol to previous patients where the ERAS protocol was not used to see if the ERAS protocol works to reduce post-surgery pain. Participants will be asked to: * Drink a pre-surgery carbohydrate drink two hours before your surgery. * Take a pre-surgery dose of Tylenol by mouth. * Take a pre-surgery dose of Gabapentin by mouth. * The surgeon will administer a local numbing medication at the surgery site by injection during the surgery. * Begin walking with assistance about 12 hours after your surgery. * Allow the research staff to collect data about your kidney function. This data will be collected on your postoperative clinic visits, which generally occur about twice weekly for one month. This information will determine your kidney health, need for hospitalization, and side effects that may occur.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-21; most recent amendment 2026-01-26.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-10-03
Trial Details
NCT Number NCT06997016
Lead Sponsor Baylor Research Institute
Conditions Postoperative Pain
Enrollment 60 participants
Start Date 2025-05-05
Primary Completion 2026-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-27